NDC 49281-246 - IMOVAX RABIES
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 49281-246
- Package NDCs from labels
- 49281-246-58
- Manufacturer
- Sanofi Vaccines US Inc. | Sanofi Winthrop Industrie
- Effective date
- 2026-02-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| IMOVAX RABIES - Sanofi Vaccines US Inc. | Sanofi Winthrop Industrie | Sanofi Vaccines US Inc. | Sanofi Winthrop Industrie | 2026-02-02 | VACCINE LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49281-246-58 | IMOVAX RABIES | 1 mL in 1 VIAL, SINGLE-USE | INJECTION, POWDER, LYOPHILIZED, | 1 mL | 2.5 [iU] in 1mL | 24 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) | ACTIVE INGREDIENT | C4HQF74XMW | IMOVAX RABIES (RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) AND WATER) KIT [SANOFI PASTEUR INC.] | 6 | |
| RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) | ACTIVE MOIETY | C4HQF74XMW | IMOVAX RABIES (RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) AND WATER) KIT [SANOFI PASTEUR INC.] | 6 | |
| ALBUMIN (HUMAN) | INACTIVE INGREDIENT | ZIF514RVZR | IMOVAX RABIES (RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) AND WATER) KIT [SANOFI PASTEUR INC.] | 6 | |
| NEOMYCIN SULFATE | INACTIVE INGREDIENT | 057Y626693 | IMOVAX RABIES (RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) AND WATER) KIT [SANOFI PASTEUR INC.] | 6 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TopCare Triple Antibiotic Plus Pain Relief | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE | Topco Associates LLC | 0fc0dbc6-ca1d-42be-8016-68e64f119706 | 2025-07-15 | Warnings | 057Y626693 |
| Triple Antibiotic Plus Pain Relief | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE | Walgreen Company | e2b7fc5b-c796-4ed1-aea7-4c810df250d5 | 2025-07-15 | Warnings | 057Y626693 |
| Publix antibiotic plus Pain Relief | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE | Publix Super Markets Inc | d0193bf1-a257-490e-a058-5e6a514981da | 2025-07-15 | Warnings | 057Y626693 |
| Live Better Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, AND POLYMYXIN B SULFATE | The Great Atlantic & Pacific Tea Company | 7d3435ad-7d73-4db6-8019-3040b3dadfa9 | 2025-07-14 | Warnings | 057Y626693 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, AND POLYMYXIN B SULFATE | Wal-Mart Stores, Inc. | f5199476-1ce2-4a82-9685-40d78b7a8935 | 2025-07-14 | Warnings | 057Y626693 |
| Antibiotic Plus Pain Relief | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE | TARGET Corporation | 6fba5890-f48f-4302-a8ac-5087a6e03bd5 | 2025-07-11 | Warnings | 057Y626693 |
| TopCare Antibiotic Plus Pain Relief | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE | Topco Associates LLC | 55dc4025-f07f-41b2-8b18-6a11ee04b5cc | 2025-07-11 | Warnings | 057Y626693 |
| Sterile Water | STERILE WATER | Nephron Pharmaceuticals Corporation | bc04a883-babc-87a6-e053-2995a90a3dfd | 2025-07-11 | Warnings, Adverse reactions | 059QF0KO0R |
| TRIPLE ANTIBIOTIC PLUS PAIN RELIEF | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE | GENOMMA LAB USA, INC. | 506fcda5-df44-49c8-8dbd-cab7434b06b2 | 2025-07-02 | Warnings | 057Y626693 |
| Curad Maximum Strength Triple Antibiotic | BACITRACIN, NEOMYCIN, POLYMYXIN B, PRAMOXINE HYDROCHLORIDE | Medline Industries, LP | 99e9c394-ebf1-7a27-e053-2a95a90ab157 | 2025-07-01 | Warnings | 057Y626693 |
| Triple Antibiotic plus Pain Relief Maximum Strength | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND PRAMOXINE HYDROCHLORIDE | Chain Drug Consortium, LLC | 55ef2205-aaf1-4aa4-917f-2b4cfa43b77e | 2025-07-01 | Warnings | 057Y626693 |
| Meret Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Nantong Health & Beyond Hygienic Products Inc. | 385d8642-9eae-a750-e063-6394a90a7931 | 2025-06-24 | Warnings | 057Y626693 |
| Plaque identifying | PLAQUE IDENTIFYING | Shenzhen Yagao Technology Co., Ltd. | 37eeb656-22f1-7372-e063-6394a90ad041 | 2025-06-19 | Warnings | 059QF0KO0R |
| ProCure Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Twin Med LLC | 37a3916f-cc1a-41a0-e063-6394a90a35ed | 2025-06-16 | Warnings | 057Y626693 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, POLYMYXIN B | J&A Digital Inc. | 9b8f2046-5886-440d-a7fc-a71138d7f34b | 2025-06-02 | Warnings | 057Y626693 |
| Sterile Water | WATER | Henry Schein, Inc. | 88403fcf-a276-42c0-88b6-bd84a720b564 | 2025-05-29 | Warnings, Adverse reactions | 059QF0KO0R |
| Eyesaline Emergency Eyewash | STERILE EYESALINE EYEWASH | Honeywell Safety Products USA, Inc. | 2d567518-4c54-7448-e063-6294a90a3e64 | 2025-05-14 | Warnings | 059QF0KO0R |
| SionBiotext Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Sion Biotext Medical Ltd | 35083d42-5823-eeb1-e063-6294a90acafa | 2025-05-13 | Warnings | 057Y626693 |
| Multi Action | BACITRACINZINC,NEOMYCINSULFATE,POLYMYXINBSULFATE,PRAMOXINEHCL | Trifecta Pharmaceutical USA LLC | b98082f3-be95-49fb-e053-2a95a90a37b8 | 2025-05-13 | Warnings | 057Y626693 |
| Leader Triple antibiotic and pain relief | BACITRACIN,NEOMYCIN,POLYMXIN, PRAMOXINE | Cardinal Health 110 dba LEADER | f4c521d9-dd05-1c23-e053-2995a90a6e2c | 2025-05-13 | Warnings | 057Y626693 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.